Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Darunavir/Ritonavir is a protease inhibitor combination used in HIV therapy. Ritonavir acts as a pharmacokinetic booster to enhance Darunavir bioavailability. The formulation typically involves co-crystallization or solid dispersion processes. Molecular formula: C27H39N3O7S2 (Darunavir); CAS: 149561-19-5.
Contraindicated with strong CYP3A inducers. Store below 25°C in dry conditions. Strictly adhere to GMP standards during synthesis to prevent impurity formation.